Cormedix Share Price Today (NASDAQ: CRMD)

Name: Cormedix Share Price (NASDAQ: CRMD) - Stock Quote, Live Chart
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Cormedix share price is 12.28 & ₹1,051.72 as on 17 May 2025, 2.30 'hrs' IST

$12.28

▲

0.59

(5%)

Market is closed - opens 7 PM, 19 May 2025

View live Cormedix share price in Dollar and Rupees. Guide to invest in Cormedix stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Cormedix, along with analyst recommendations, forecasts, and comprehensive financials.

Cormedix share price movements

Today's Low: $11.72
Today's High: $12.31
$12.28
4.56%
Downside
Day's Volatility :4.79%
Upside
0.24%
52 Weeks Low: $3.61
52 Weeks High: $13.85
$12.28
70.6%
Downside
52 Weeks Volatility :73.94%
Upside
11.34%

Cormedix (CRMD) Returns

Period	Cormedix Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	15.48%	-9.1%	0.0%
6 Months	12.51%	-5.7%	0.0%
1 Year	143.07%	-9.0%	0.0%
3 Years	265.33%	3.8%	-0.4%

Cormedix (CRMD) Key Statistics

in dollars & INR

Previous Close	$11.69
Open	$11.72
Today's High	$12.31
Today's Low	$11.72
Market Capitalization	$792.9M
Today's Volume	$1.4M
52 Week High	$13.85
52 Week Low	$3.61
Revenue TTM	$82.6M
EBITDA	$14.9M
Earnings Per Share (EPS)	$0.25
PE Ratio	46.76
Profit Margin	20.81%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	19.87%

How to invest in Cormedix Stock (CRMD) from India?

It is very easy for Indian residents to invest directly in Cormedix from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cormedix stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cormedix or CRMD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cormedix or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cormedix shares which would translate to 0.070 fractional shares of Cormedix as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Cormedix, in just a few clicks!

Returns in Cormedix (CRMD) for Indian investors in Rupees

The Cormedix stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Cormedix investment value today

Current value as on today

₹2,45,900

Returns

₹1,45,900

(+145.9%)

Returns from Cormedix Stock

₹1,43,168 (+143.17%)

Dollar Returns

₹2,731 (+2.73%)

Indian investors sentiment towards Cormedix (CRMD)

314%

Period: Apr 18, 2025 to May 18, 2025. Change in 30 Days versus previous period

Search interest for Cormedix Stock from India on INDmoney has increased by 314% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Cormedix

BlackRock Inc
6.74%
Vanguard Group Inc
4.98%
Elliott Investment Management LP
4.23%
State Street Corp
2.14%
Geode Capital Management, LLC
2.05%
First Turn Management LLC
1.51%

Analyst Recommendation on Cormedix

Rating

Trend

Buy

90%Buy

10%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Cormedix(by analysts ranked 0 to 5 stars)

Analyst Forecast on Cormedix Stock (CRMD)

What analysts predicted

Upside of 37.08%

Target:

$16.83

Current:

$12.28

Insights on Cormedix Stock (Ticker Symbol: CRMD)

Price Movement
In the last 1 month, CRMD stock has moved up by 60.0%
Increasing Revenue
Revenue is up for the last 7 quarters, 6.81K → 39.08M (in $), with an average increase of 67.7% per quarter
Increasing Net Profit
Netprofit is up for the last 6 quarters, -14.75M → 20.64M (in $), with an average increase of 113.9% per quarter

Cormedix Technicals Summary

Sell

Neutral

Buy

Cormedix is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Cormedix (CRMD) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Cormedix Inc	50.8%	12.51%	143.07%	265.33%	197.22%
Regeneron Pharmaceuticals, Inc.	5.81%	-22.03%	-39.82%	-10.14%	2.98%
Vertex Pharmaceuticals Incorporated	-8.14%	-6.07%	-1.62%	69.63%	54.11%
Alnylam Pharmaceuticals, Inc.	22.5%	22.76%	89.78%	115.57%	98.77%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Cormedix Inc	46.76	46.76	0.0	0.8	0.2	0.08	NA	1.7
Regeneron Pharmaceuticals, Inc.	14.86	14.86	1.26	35.5	0.16	0.07	0.01	277.5
Vertex Pharmaceuticals Incorporated	32.84	NA	2.59	18.0	-0.06	0.12	NA	64.2
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	1.06	-15.01	-0.02	NA	0.89

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Cormedix Inc	Buy	$792.9M	197.22%	46.76	20.81%
Regeneron Pharmaceuticals, Inc.	Buy	$63.2B	2.98%	14.86	31.94%
Vertex Pharmaceuticals Incorporated	Buy	$111.5B	54.11%	32.84	-8.91%
Alnylam Pharmaceuticals, Inc.	Buy	$34.9B	98.77%	NA	-11.49%

About Cormedix

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

Organization	Cormedix
Employees	64
CEO	Mr. Joseph Todisco MBA
Industry	Health Technology

Management People of Cormedix

Name	Title
Mr. Joseph Todisco MBA	CEO & Director
Dr. Matthew T. David M.D.	Executive VP & CFO
Ms. Elizabeth Masson-Hurlburt B.A.	Executive VP and Chief Clinical Strategy & Operations Officer
Ms. Kaufman Beth Zelnick Esq.	EVP, Chief Legal, Compliance Officer & Corporate Secretary
Donna Ucci	Senior VP & Head of Global Quality
Dr. Tushar Mukherjee	Senior VP & Head of Technical Operations
Ms. Erin Mistry	Executive VP & Chief Commercial Officer

Important FAQs about investing in CRMD Stock from India :

Can Indians buy Cormedix shares?

Yes, Indians can invest in the Cormedix (CRMD) from India.

With INDmoney, you can buy Cormedix at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Cormedix at zero transaction cost.

How can I buy Cormedix shares from India?

It is very easy to buy Cormedix from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cormedix (CRMD) be purchased?

Yes, you can buy fractional shares of Cormedix with INDmoney app.

What are the documents required to start investing in Cormedix stocks?

To start investing in Cormedix, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Cormedix share price today?

Cormedix share price today stands at $12.28, Open: $11.72 ; Previous Close: $11.69 ; High: $12.31 ; Low: $11.72 ; 52 Week High: $13.85 ; 52 Week Low: $3.61.

The stock opens at $11.72, after a previous close of $11.69. The stock reached a daily high of $12.31 and a low of $11.72, with a 52-week high of $13.85 and a 52-week low of $3.61.